isoxazoles has been researched along with Liver Steatosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Y; Huang, J; Liu, S; Lu, Y; Ning, G; Shen, W; Wang, H; Yang, J; Yang, Y; Zhang, D; Zhang, Q; Zhang, R; Zhu, R | 1 |
| Amin, SG; Bisson, WH; Brocker, CN; Desai, D; Gavrilova, O; Gonzalez, FJ; Jiang, C; Krausz, KW; Li, J; Liu, Y; Lv, Y; Patterson, AD; Shi, J; Xie, C | 1 |
| Ben, P; Lan, L; Luo, L; Qi, Z; Shen, L; Song, X; Xuan, C; Yin, Z; Zhu, Y | 1 |
| Haga, S; Ozaki, M | 1 |
| Cariou, B | 1 |
| Baldelli, F; Basile, F; Cipriani, S; D'Amore, C; Fiorucci, S; Francisci, D; Mencarelli, A; Renga, B; Schiaroli, E | 1 |
| Gao, M; Huang, Y; Liu, D; Ma, Y; Yan, L | 1 |
7 other study(ies) available for isoxazoles and Liver Steatosis
| Article | Year |
|---|---|
Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis.
Topics: Animals; Cells, Cultured; Chemokines; Disease Progression; Down-Regulation; Fatty Liver; Gene Expression Regulation; HEK293 Cells; Hep G2 Cells; Humans; Intercellular Signaling Peptides and Proteins; Isoxazoles; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear | 2013 |
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction.
Topics: Adolescent; Adult; Aged; Animals; Ceramides; Cholic Acids; Diet, High-Fat; Fatty Liver; Female; Glycine; Humans; Ileum; Insulin Resistance; Intestinal Mucosa; Isoxazoles; Liver; Male; Mice; Middle Aged; Obesity; Receptors, Cytoplasmic and Nuclear; Young Adult | 2015 |
Phosphorylated heat shock protein 27 promotes lipid clearance in hepatic cells through interacting with STAT3 and activating autophagy.
Topics: Animals; Anisoles; Autophagy; Cell Line; Diet, High-Fat; eIF-2 Kinase; Eukaryotic Initiation Factor-2; Fatty Liver; Heat-Shock Proteins; Hepatocytes; HSP27 Heat-Shock Proteins; Humans; Isoxazoles; Lipids; Liver; Lysosomes; Male; Mice; Mice, Inbred C57BL; Molecular Chaperones; Neoplasm Proteins; Palmitates; Phosphorylation; Protein Binding; STAT3 Transcription Factor | 2016 |
Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.
Topics: Adaptor Proteins, Signal Transducing; Adipogenesis; Animals; Apoptosis; Cell Survival; Fatty Liver; Hepatectomy; Hepatocytes; Isoxazoles; Liver; Liver X Receptors; Mice; NF-E2-Related Factor 2; Receptors, Cytoplasmic and Nuclear; Sequestosome-1 Protein; Signal Transduction; Up-Regulation | 2017 |
The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
Topics: Animals; Bile Acids and Salts; Chromosome Mapping; Chromosomes, Human, Pair 12; Disease Models, Animal; DNA-Binding Proteins; Fatty Liver; Humans; Insulin; Isoxazoles; Liver Regeneration; Mice; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2008 |
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Dyslipidemias; Epididymis; Fatty Liver; HIV Protease Inhibitors; Isoxazoles; Leflunomide; Lipodystrophy; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Ritonavir | 2012 |
Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.
Topics: Animals; CD36 Antigens; Cell Line; Diet, High-Fat; Fatty Liver; Gene Expression Regulation; Isoxazoles; Lipid Metabolism; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cytoplasmic and Nuclear; Weight Gain | 2013 |